✦ LIBER ✦

Su1058 Early Stopping Rules for Faldaprevir Plus Pegylated Interferon α-2A and Ribavirin in Treatment-Naïve Patients: Exploratory Study of Pooled Data From Phase III Trials

✍ Scribed by Ferenci, Peter; Dieterich, Douglas T.; Zeuzem, Stefan; Mantry, Parvez S.; Sarrazin, Christoph; Crespo, Javier; Tam, Edward; Dufour, Jean-Francois; Yoshida, Eric M.; Nishiguchi, Shuhei; Bourliere, Marc; Omata, Masao; Abergel, Armando; Kuboki, Makoto; Carvalho, Armando; Peng, Cheng-Yuan; Romero-Gomez, Manuel; Wright, David; Stern, Jerry O.; Böcher, Wulf; Kukolj, George; Gallivan, John-Paul; Scherer, Joseph; Jensen, Donald M.

Book ID: 122248435
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 233 KB
Volume: 146
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(14)63549-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P1121 EARLY STOPPING RULES FOR FALDAPREV

P1121 EARLY STOPPING RULES FOR FALDAPREVIR PLUS PEGYLATED INTERFERON a-2a AND RIBAVIRIN IN TREATMENT-NAIVE PATIENTS: EXPLORATORY STUDY OF POOLED DATA FROM PHASE III TRIALS

✍ Ferenci, P.; Dieterich, D.; Zeuzem, S.; Mantry, P.; Sarrazin, C.; Crespo, J.; Ta 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 83 KB

Su1056 Effect of HCV Genotype-1 Subtype

Su1056 Effect of HCV Genotype-1 Subtype on Response to Faldaprevir Plus Pegylated Interferon α-2A and Ribavirin in Treatment-Naïve Patients: Pooled Data From Phase III Trials

✍ Jacobson, Ira M.; Jensen, Donald M.; Dieterich, Douglas T.; Sarrazin, Christoph; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 397 KB

P1129 EFFECT OF HCV GENOTYPE-1 SUBTYPE O

P1129 EFFECT OF HCV GENOTYPE-1 SUBTYPE ON RESPONSE TO FALDAPREVIR PLUS PEGYLATED INTERFERON a-2a AND RIBAVIRIN IN TREATMENT-NAIVE PATIENTS: POOLED DATA FROM PHASE III TRIALS

✍ Jacobson, I.M.; Jensen, D.M.; Dieterich, D.; Sarrazin, C.; Foster, G.R.; Yoshida 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 67 KB

Su1049 Faldaprevir Plus Pegylated Interf

Su1049 Faldaprevir Plus Pegylated Interferon Alfa-2A and Ribavirin in Treatment-Naïve Patients With Chronic Hepatitis C Genotype-1 Infection: A Pooled Analysis of Two Randomized, Double-Blind Placebo-Controlled Phase III Trials (Startverso1&2)

✍ Jensen, Donald M.; Foster, Graham; Ferenci, Peter; Cooper, Curtis; Dieterich, Do 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 292 KB